Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Celastrol
Nanjing Legend Biotech Co.
Safety
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety Issues
1 trial -
Citalopram
COGNITION THERAPEUTICS INC
Antidepressive Agents, Second-Generation
1 trial -
Citrus Limonoid Beverage
United Therapeutics Europe Ltd
Hypercholesterolemia
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
Peking University Third Hospital
Prostate Cancer
1 trial -
Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Control (Standard treatment)
Grace Therapeutics
Moisture Associated Skin Damage
1 trial -
Cyclophosphamide
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ERAS
1 trial -
Dexlansoprazole
Takeda
Laryngo-pharyngeal Reflux
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiac Surgery
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Old Age
1 trial -
Dexmedetomidine injection
United Therapeutics Europe Ltd
Delirium in Old Age
1 trial -
Dexmedetomidine supplemented morphine analgesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Elderly
1 trial -
Dexmedetomidine-Esketamine Combination
The First People's Hospital of Lianyungang
Aged
1 trial -
Diagnostic Test: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT
The First People's Hospital of Lianyungang
DLL3-expressing Tumors
1 trial -
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
Docetaxel
The First People's Hospital of Lianyungang
Esophageal Neoplasms
1 trial -
Elmental diet
Hospital Authority, Hong Kong
Gastro-oesophageal Reflux
1 trial -
Enteral immunonutrition
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Nasopharyngeal Carcinoma
1 trial -
Erythromycin 4% topical gel formulation:
BRIGHT MINDS BIOSCIENCES INC.
Inflammation; Skin
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources